The Food and Drug Administration (FDA or Agency) is announcing a hybrid public meeting to discuss proposed recommendations for the reauthorization of the Over-the-Counter Monograph Drug User Fee program (OMUFA) for fiscal years (FYs) 2026 through 2030. The virtual public meeting will be held on November 20, 2024, from 9 a.m. to 12:30 p.m. (ET).